MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
暂无分享,去创建一个
[1] M. Alonso-Riaño,et al. Lung adenocarcinoma during pregnancy: clinical case and literature review , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[2] J. Xia,et al. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] Qingfeng Ni,et al. Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway. , 2018, Human pathology.
[4] S. Pan,et al. miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4 , 2018, Oncotarget.
[5] D. Gilot,et al. miRNA displacement as a promising approach for cancer therapy , 2018, Molecular & cellular oncology.
[6] X. Liu,et al. MicroRNA-143 regulates the proliferation and apoptosis of cervical cancer cells by targeting HIF-1α. , 2017, European review for medical and pharmacological sciences.
[7] N. Kanarek,et al. Barriers to non-small cell lung cancer trial eligibility , 2017, Contemporary clinical trials communications.
[8] Kailv Sun,et al. NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway , 2017, Oncotarget.
[9] K. Rabe,et al. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. , 2017, The New England journal of medicine.
[10] S. Mowla,et al. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[11] R. Huang,et al. The EMT spectrum and therapeutic opportunities , 2017, Molecular oncology.
[12] Zhe Zhang,et al. miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer. , 2017, Gene.
[13] N. Zhang,et al. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression. , 2017, International journal of oncology.
[14] W. Sha,et al. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin , 2016, International journal of molecular medicine.
[15] Ting Deng,et al. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer , 2016, Oncotarget.
[16] Jiateng Zhong,et al. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1 , 2016, Tumor Biology.
[17] A. Hague,et al. The PI3K/Akt Pathway in Tumors of Endocrine Tissues , 2016, Front. Endocrinol..
[18] K. Nan,et al. BMI-1, a promising therapeutic target for human cancer. , 2015, Oncology letters.
[19] Xiefu Zhang,et al. MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1 , 2015, Tumor Biology.
[20] Q. Yao,et al. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells , 2015, Cancer Gene Therapy.
[21] C. M. Eischen,et al. Differences in miRNA Expression in Early Stage Lung Adenocarcinomas that Did and Did Not Relapse , 2014, PloS one.
[22] M. Mino‐Kenudson,et al. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review , 2014, Current opinion in pulmonary medicine.
[23] Fangzhou Song,et al. Bmi-1 regulates epithelial-to-mesenchymal transition to promote migration and invasion of breast cancer cells. , 2014, International journal of clinical and experimental pathology.
[24] A. Pandiella,et al. Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis , 2014, PloS one.
[25] Liang Zhou,et al. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. , 2013, International journal of oncology.
[26] Xinyu Zhao,et al. shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis. , 2012, Lung cancer.
[27] Z. Leng,et al. Bmi-1 Promotes the Chemoresistance, Invasion and Tumorigenesis of Pancreatic Cancer Cells , 2012, Chemotherapy.
[28] Libing Song,et al. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer , 2011, Molecular Cancer.
[29] R. W. Matheny,et al. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts. , 2009, Biochemical and biophysical research communications.
[30] Libing Song,et al. Bmi‐1 expression predicts prognosis for patients with gastric carcinoma , 2008, Journal of surgical oncology.
[31] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[32] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[33] Hai-tao Xu,et al. MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR. , 2016, Clinical laboratory.
[34] P. Savagner. Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity. , 2015, Current topics in developmental biology.
[35] Libing Song,et al. [Expression and significance of Bmi-1 in breast cancer]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.